Navigation Links
Merck, ICMR to conduct joint trials on cervical cancer vaccine

Merck & Co, known as MSD India, has entered into a collaboration with the Indian Council of Medical Research (ICMR) to conduct studies on the former's investigational cervical cancer drug, Gardasil.//

This is the first public-private partnership in vaccine development in India. Under the agreement, clinical trials will be conducted for a human pappiloma virus (HPV) vaccine that causes cervical cancer.

The vaccine that has been developed by Merck and will be tried on 30 to 40,000 women in two phases. The volunteers will be between 17 and 18 years of age.

While the first phase will take two years, the second will take four years to complete and the cost of the trials is estimated to be around $45 million.

The Indian trials will be carried out to see if it's safe and equally efficacious for women in a tropical country.

Upon completion of the study in India, the two partners will work together to assess the efficacy of the vaccine in the Indian population and identifying ways of providing the same.

The New Jersey-headquartered pharma company has already applied for permission from the Food and Drug Administration (FDA) to launch the vaccine in the US market and is likely to apply for regulatory approval for the EU region soon.

This study is in addition to the Phase III clinical trials that have to be completed for any drug to be approved by the regulator. Dr Leonard Tauro, MD, MSD India says, "We want to know how the vaccine would respond to the Indian conditions."

The company will supply the vaccine free of cost for its use in the study. Gardasil is designed to protect against four types of human papillomavirus (HPV) - 6, 11, 16 and 18. Besides Merck, GSK too is working on a similar vaccine.

About 5.1 lakh cases of cervical cancer are reported every year the world over, with nearly 80 per cent occurring in developing countries. The World Health Organization terms cervical cancer the mo st common form of cancer in India with over 1.3 lakh cases reported each year and 74,000 women dying annually.

The clinical trials with Merck's HPV vaccine would test its role in controlling the spread of the disease in India. If found successful, it may open a feasible option for MSD to market the drug in other developing countries.

Merck says that collaborative partnerships between industry, NGOs and individual governments are critical in determining the best approach to the introduction of investigational medicines and vaccines in the public sector of low-income countries.

ICMR is one of the oldest medical research councils in the world. It started in 1911 as the Indian Research Fund Association (IRFA) and was renamed ICMR in 1950, soon after Independence, on the recommendations of the health survey and development committee, headed by Sir Joseph Bhore. It has a network of 26 research institutes and over 70 field stations in various parts of the country, and has an annual budget of Rs. 231 crore (Rs. 2310 million).


'"/>




Related medicine news :

1. NBE to conduct test for medical students from abroad
2. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
3. India to maintain Public domain Registry database of clinical trials conducted in India.
4. New Sexual Misconduct Rule Against Doctors In The US
5. Diabetic check-up conducted in Chitradurga
6. Bird flu test conducted in dead pigeon found in Ethiopia
7. Nurse accused of breach of conduct and duty
8. APEC to conduct mock bird flu exercise
9. UK doctor Charged By GMC For Professional Misconduct
10. GP Found Guilty Of Misconduct
11. Mammoottys fan club to help conduct eye camps
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has been ... Atlanta Football Host Committee (AFHC) for the 2018 College Football ... 8, 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... the AFHC "I,m In" campaign, participating in many activities leading ... ...
Breaking Medicine Technology: